|Articles|November 15, 2016

Schulman IRB and iMedRIS Announce Partnership

Schulman IRB and iMedRIS Data Corporation announce a partnership to provide research organizations with integrated technology, consulting and IRB review services.

Read the full release here

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe

Schulman IRB and iMedRIS Announce Partnership

Related Content

ACT Brief: Bridging Site-Sponsor Data Gaps, Major Study Retraction, and TNBC First-Line Approval

Nature Medicine Retracts Viral Lung Cancer Timing Study After Four-Month Investigation

Jonathan Andrus, CRIO, on Why Site-Sponsor Data Fragmentation Persists and What Central eSource Can Do About It

ACT Brief: DIA Leadership Amid Uncertainty, Reimagining CRO Contracts, and Eli Lilly Expansion

2026 DIA Global Annual Meeting: On Leadership, Obesity, and the Science That's Redefining What's Possible

Trending on Applied Clinical Trials Online

Nature Medicine Retracts Viral Lung Cancer Timing Study After Four-Month Investigation

Beyond Revenue Recognition: Rethinking CRO Contracting Through the CURED Shared Performance Contract

Two Decades of Rising Protocol Complexity: A Longitudinal Analysis of Clinical Trial Design Evolution, 2004–2025

ACT Brief: DIA Leadership Amid Uncertainty, Reimagining CRO Contracts, and Eli Lilly Expansion

HHS Launches Operation TrialBlazer to Restore US Leadership in Clinical Research